5 Copper Complexes – A Unique Class of Anti-Arthritic Drugs (Q41209483)

28 September 2017

1 reference

reason for preferred rank

title

5 Copper Complexes – A Unique Class of Anti-Arthritic Drugs (English)

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70257-1

28 June 2022

Copper complexes - a unique class of anti-arthritic drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A400612

28 June 2022

author name string

J. R. Sorenson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A400612

28 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=400612

28 June 2022

publication date

1 January 1978

1 reference

Progress in medicinal chemistry

28 September 2017

published in

1 reference

28 September 2017

volume

15

1 reference

28 September 2017

page(s)

211-260

1 reference

Copper homeostasis in the mammalian system

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXIX. THE ANEMIA OF INFECTION. STUDIES ON THE IRON-BINDING CAPACITY OF SERUM.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Serum copper, serum iron and total iron-binding capacity of serum in acute and chronic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Studies on zinc in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

The electrocardiographic work and hypoxemia tests

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Studies on copper metabolism. X. Factors influencing the plasma copper level of the albino rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Serum Copper in Psoriasis and Other Dermatoses

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

THE FREE RADICAL THEORY OF AGING: EFFECT OF AGE ON SERUM COPPER LEVELS

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Raised serum copper and caeruloplasmin levels in subjects taking oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Caeruloplasmin and green plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Plasma-zinc and copper in pregnancy and after oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

A simple automated micromethod for measuring serum copper

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Serum copper, serum iron and total iron-binding capacity of serum in patients with chronic rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Turnover of 131-I-labelled ceruloplasmin in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

WHOLE-BLOOD CONCENTRATIONS OF COPPER AND ZINC IN RHEUMATOID ARTHRITIS STUDIED BY ACTIVATION ANALYSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Concentration and chemical state of copper in synovial fluid and blood serum of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Serum copper levels in rheumatoid arthritis: relationship of elevated copper to protein alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Nonceruloplasmin copper in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Redox Control of Lysosomes in Human Synovia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Chelation in medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Copper chelates as possible active forms of the antiarthritic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Some copper coordination compounds and their antiinflammatory and antiulcer activities

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Trace metal composition of synovial fluid and blood serum of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Letter: Significance of plasma copper and caeruloplasmin concentrations in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Significance of plasma copper and caeruloplasmin concentrations in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Characterization of the proteins of human synovial fluid in certain disease states

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Trace metal composition of synovial fluid from patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Treatment of rheumatoid and degenerative diseases with copper complexes: a review with emphasis on copper-salicylate

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Copper and Gold Salts in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Copper therapy of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Copper treatment of experimental and clinical arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Therapeutic criteria in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Treatment of rheumatoid arthritis with organic copper compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Studies on the function and metabolism of copper

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

[Therapy of rheumatic diseases with a copper-sodium salicylate complex compound (permalon)]

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Anti-inflammatory drugs, prostaglandins and leucocyte migration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Perfusion of intact skin by a saline solution of bis(glycinato) copper(II)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Copper and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Synthesis and Biological Evaluation of Tetrakis(Acetylsalicylato)‐μ‐Dicopper(II)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Concerning the merits of copper aspirin as a potential anti-inflammatory drug

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

The role of copper in preventing gastrointestinal damage by acidic anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Gastric mucus effusion elicited by oral copper compounds: Potential anti-ulcer activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Copper-induced activation of aortic lysyl oxidase in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Regeneration of gastric mucosa in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Cofactors in the biosynthesis of prostaglandins F1α and F2α

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

The role of copper in prostaglandin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Blockade by metal complexing agents and by catalase of the effects of arachidonic acid on platelets: Relevance to the study of anti-inflammatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Free radicals and inflammation: protection of synovial fluid by superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Superoxide dismutases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Superoxide dismutase activity of low molecular weight Cu2+ -chelates studied by pulse radiolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Mechanism of superoxide anion scavenging reaction by bis-(salicylato)-copper(II) complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970257-1

7 January 2021

Evaluation of copper complexes as potential anti-arthritic drugs

98

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70257-1

Problems Concerning the Biochemical Action of Superoxide Dismutase (Erythrocuprein)

21 April 2023

112

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70257-1

Superoxide Dismutase Activity of Cu(Tyr)2and Cu, Co-Erythrocuprein

21 April 2023

113

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70257-1

Inhibition of the Cathepsin D-Type Proteinase of Macrophages by Pepstatin, a Specific Pepsin Inhibitor, and Other Substances

21 April 2023

115

1 reference

https://api.crossref.org/works/10.1016/S0079-6468(08)70257-1

21 April 2023

Identifiers

0 references

1 reference